Latest & greatest articles for deafness

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on deafness or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on deafness and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for deafness

1. Bilateral cochlear implants for children with severe-to-profound sensorineural hearing loss in both ears

Bilateral cochlear implants for children with severe-to-profound sensorineural hearing loss in both ears 1 Driving better decision-making in healthcare Bilateral cochlear implants for children with severe-to-profound sensorineural hearing loss in both ears Technology Guidance from the MOH Medical Technology Advisory Committee Guidance Recommendations The Ministry of Health’s Medical Technology Advisory Committee has recommended: ? Bilateral cochlear implants (BCI) for the management of children (...) for the technology evaluation of bilateral cochlear implants (BCI) for children with severe-to-profound sensorineural hearing loss in both ears in 2017. A subsequent evaluation on replacement cochlear implant (CI) sound processors was presented to the Committee in 2019. The Agency for Care Effectiveness conducted the evaluation in consultation with an MOH expert working group comprising clinicians, audiologists, medical social workers, and educators. The evidence was used to inform the Committee’s deliberations

2020 Appropriate Care Guides, Agency for Care Effectiveness (Singapore)

2. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss

Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss Published March 2020 Volume 20, Number 1 ONTARIO HEALTH TECHNOLOGY ASSESSMENT SERIES Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment KEY MESSAGES What Is This Health Technology Assessment About? Single-sided deafness is profound sensorineural hearing loss (damage to the hearing organ or hearing nerve in the inner ear) or non-functional hearing (...) be. It also looked at the experiences, preferences, and values of people with single-sided deafness or conductive or mixed hearing loss. What Did This Health Technology Assessment Find? The best available evidence shows that cochlear and bone-conduction implants helped people with single-sided deafness or conductive or mixed hearing loss hear better and improved their hearing-specific quality of life. For people with single-sided deafness, cochlear implants may be cost-effective compared with no hearing

2020 Health Quality Ontario

3. Interpreter on Wheels - Video remote interpreting and video relay services for deaf people with mental health problems

Interpreter on Wheels - Video remote interpreting and video relay services for deaf people with mental health problems Interpreter on Wheels - Health Technology Wales > Interpreter on Wheels Interpreter on Wheels Topic Status Complete Video remote interpreting and video relay services for deaf people with mental health problems. Summary Health Technology Wales researchers searched for evidence on the clinical and cost effectiveness of video remote interpreting and video relay services (...) at this document because We may like to contact you by email to find out more about how you used the documents. I am happy for HTW to contact me by email for feedback on how I use HTW documents Comments This field is for validation purposes and should be left unchanged. This iframe contains the logic required to handle Ajax powered Gravity Forms. × Suggest a topic If there's a technology that you'd like us to appraise then we'd love to hear from you. Newsletter Keeping you up-to-date with periodic news

2019 Health Technology Wales

4. Sudden Hearing Loss Full Text available with Trip Pro

obtain, or refer to a clinician who can obtain, audiometry as soon as possible (within 14 days of symptom onset) to confirm the diagnosis of sudden sensorineural hearing loss. (KAS 6) Clinicians should evaluate patients with sudden sensorineural hearing loss for retrocochlear pathology by obtaining magnetic resonance imaging or auditory brainstem response. (KAS 10) Clinicians should offer, or refer to a clinician who can offer, intratympanic steroid therapy when patients have incomplete recovery from (...) is emphasized. KAS 5—New studies were added to confirm the lack of benefit of nontargeted laboratory testing in sudden sensorineural hearing loss. KAS 6—Audiometric follow-up is excluded as a reasonable workup for retrocochlear pathology. Magnetic resonance imaging, computerized tomography scan if magnetic resonance imaging cannot be done, and, secondarily, auditory brainstem response evaluation are the modalities recommended. A time frame for such testing is not specified, nor is it specified which

2019 American Academy of Otolaryngology - Head and Neck Surgery

5. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. (Abstract)

Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. Platinum-based therapy, including cisplatin, carboplatin, oxaliplatin or a combination of these, is used to treat a variety of paediatric malignancies. One of the most significant adverse effects is the occurrence of hearing loss or ototoxicity. In an effort to prevent this ototoxicity, different otoprotective medical interventions have been studied. This review is the third update of a previously (...) published Cochrane Review.To assess the efficacy of medical interventions to prevent hearing loss and to determine possible effects of these interventions on antitumour efficacy, toxicities other than hearing loss and quality of life in children with cancer treated with platinum-based therapy as compared to placebo, no additional treatment or another protective medical intervention.We searched the Cochrane Central Register of Controlled Trials, MEDLINE (PubMed) and Embase (Ovid) to 8 January 2019. We

2019 Cochrane

6. Cochlear implants for children and adults with severe to profound deafness

from the outer to the inner ear (conductive hearing loss) or damage within the cochlea, the auditory nerve or auditory centres in the brain (sensorineural hearing loss). In adults the most common cause of sensorineural hearing loss is presbycusis. This is a progressive condition caused by the loss of function of hair cells in the inner ear, leading to deafness. Hearing loss in adults may also be caused by excessive exposure to noise, or by ototoxic drugs, metabolic disorders, infections or genetic (...) in a language in which a person is sufficiently fluent for the tests to be appropriate, other methods of assessment should be considered. [2009] [2009] Cochlear implants for children and adults with severe to profound deafness (TA566) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 5 of 302 2 Clinical need and pr Clinical need and practice actice 2.1 Hearing loss may be caused by interference with the transmission of sound

2019 National Institute for Health and Clinical Excellence - Technology Appraisals

7. Assessment of hearing loss

ear (sensory) or auditory nerve/auditory pathway (neural). Many sensorineural hearing losses are permanent because the human inner ear and hair cells have only limited ability to repair themselves, unlike avian hair cells, which can re-generate after trauma or injury. Reng D, Müller M, Smolders JWT. Functional recovery of hearing following AMPA-induced reversible disruption of hair cell afferent synapses in the avian inner ear. Audiol Neurootol. 2001 Mar-Apr;6(2):66-78. http://www.ncbi.nlm.nih.gov (...) Assessment of hearing loss Assessment of hearing loss - Differential diagnosis of symptoms | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Assessment of hearing loss Last reviewed: February 2019 Last updated: December 2018 Summary Hearing loss is one of the most common sensory impairments. It affects people of all ages and can be permanent if not treated correctly. Proper diagnosis rests on a thorough understanding of ear anatomy and physiology

2018 BMJ Best Practice

8. Support to address barriers to learning for learners who are deaf Full Text available with Trip Pro

Support to address barriers to learning for learners who are deaf There is great importance in support services for successfully addressing the barriers to learning optimally or learners who are deaf. The study, though conducted in South Africa, has national and international appeal.The aim of the study was to identify educator reflections on support services needed for them to address barriers to learning of learners who are deaf.The study used a qualitative design for collecting data (...) in natural settings. A sample size of 11 educators of learners who are deaf was purposively selected from two provinces of South Africa. The study used an open ended individual interview questionnaire.Data was analysed using qualitative content analysis considering the context of the schools in which the study was carried out. Results showed that there was: limited curriculum support in special schools; lack of support and inadequate teaching and learning materials; overcrowding in one school

2018 African journal of disability

9. The association between auditory nerve neurovascular conflict and sudden unilateral sensorineural hearing loss Full Text available with Trip Pro

The association between auditory nerve neurovascular conflict and sudden unilateral sensorineural hearing loss There may be an association between a neurovascular conflict (NVC) of the auditory nerve and unilateral sudden sensorineural hearing loss (SSNHL).Compression of cranial nerves by vascular structures can lead to significant symptomatology that may require surgical decompression. Notable examples are trigeminal neuralgia and hemifacial spasm. Magnetic resonance imaging (MRI) is part (...) of the workup for SSNHL, and it may depict an NVC of the auditory nerve. Here we look into the association between this NVC and unilateral SSNHL.A retrospective analysis was performed on all consecutive patients with unilateral SSNHL who underwent an MRI scan in our medical center. The data collected included age, gender, side and severity of hearing loss, and accompanying complaints. Each MRI scan was reviewed by a neuroradiologist who was unaware of hearing loss laterality. The presence, side, extent

2018 Laryngoscope investigative otolaryngology

10. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. Full Text available with Trip Pro

Different infusion durations for preventing platinum-induced hearing loss in children with cancer. Platinum-based therapy, including cisplatin, carboplatin or oxaliplatin, or a combination of these, is used to treat a variety of paediatric malignancies. Unfortunately, one of the most important adverse effects is the occurrence of hearing loss or ototoxicity. In an effort to prevent this ototoxicity, different platinum infusion durations have been studied. This review is the second update (...) of a previously published Cochrane review.To assess the effects of different durations of platinum infusion to prevent hearing loss or tinnitus, or both, in children with cancer. Secondary objectives were to assess possible effects of these infusion durations on: a) anti-tumour efficacy of platinum-based therapy, b) adverse effects other than hearing loss or tinnitus, and c) quality of life.We searched the electronic databases Cochrane Central Register of Controlled Trials (CENTRAL; the Cochrane Library 15

2018 Cochrane

11. Hearing loss in adults: assessment and management

not to remove earwax or clean their ears by inserting small objects, such as cotton buds, into the ear canal. Explain that this could damage the ear canal and eardrum, and push the wax further down into the ear. Hearing loss in adults: assessment and management (NG98) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 8 of 201.3 Investigation using MRI 1.3.1 Offer MRI of the internal auditory meati to adults with hearing loss (...) and localising symptoms or signs (such as facial nerve weakness) that might indicate a vestibular schwannoma or CPA (cerebellopontine angle) lesion, irrespective of pure tone thresholds. 1.3.2 Consider MRI of the internal auditory meati for adults with sensorineural hearing loss and no localising signs if there is an asymmetry on pure tone audiometry of 15 dB or more at any 2 adjacent test frequencies, using test frequencies of 0.5, 1, 2, 4 and 8 kHz. 1.4 Treating idiopathic sudden sensorineural hearing loss

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

12. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss. Full Text available with Trip Pro

Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss. Cisplatin chemotherapy and surgery are effective treatments for children with standard-risk hepatoblastoma but may cause considerable and irreversible hearing loss. This trial compared cisplatin with cisplatin plus delayed administration of sodium thiosulfate, aiming to reduce the incidence and severity of cisplatin-related ototoxic effects without jeopardizing overall and event-free survival.We randomly assigned children (...) ) for four preoperative and two postoperative courses. The primary end point was the absolute hearing threshold, as measured by pure-tone audiometry, at a minimum age of 3.5 years. Hearing loss was assessed according to the Brock grade (on a scale from 0 to 4, with higher grades indicating greater hearing loss). The main secondary end points were overall survival and event-free survival at 3 years.A total of 109 children were randomly assigned to receive cisplatin plus sodium thiosulfate (57 children

2018 NEJM Controlled trial quality: predicted high

13. Hearing Aids and Health-Related Quality of Life in Adults With Hearing Loss. (Abstract)

Hearing Aids and Health-Related Quality of Life in Adults With Hearing Loss. Are hearing aids associated with improved health-related quality of life in adults with mild to moderate hearing loss?Compared with no hearing aids, the provision of hearing aids was associated with improvements in hearing-specific and general health-related quality of life.

2018 JAMA

14. Hearing Loss and/or Vertigo

without IV contrast Usually Not Appropriate O MRA head without and with IV contrast Usually Not Appropriate O MRA head without IV contrast Usually Not Appropriate O ACR Appropriateness Criteria ® 3 Hearing Loss and/or Vertigo Variant 5: Congenital hearing loss or total deafness or cochlear implant candidate. Surgical planning. Procedure Appropriateness Category Relative Radiation Level CT temporal bone without IV contrast Usually Appropriate ??? MRI head and internal auditory canal without and with IV (...) and internal auditory canal without IV contrast, or without and with IV contrast, is recommended for evaluating patients with acquired sensorineural hearing loss. ? Variant 4: Mixed conductive and sensorineural hearing loss can be evaluated with either CT temporal bone without IV contrast, or MRI head and internal auditory canal without IV contrast, or without and with IV contrast. ? Variant 5: Congenital hearing loss, total deafness, or cochlear implant is best assessed with either CT temporal bone

2018 American College of Radiology

15. Hearing children of Deaf parents: Gender and birth order in the delegation of the interpreter role in culturally Deaf families Full Text available with Trip Pro

Hearing children of Deaf parents: Gender and birth order in the delegation of the interpreter role in culturally Deaf families Culturally, hearing children born to Deaf parents may have to mediate two different positions within the hearing and Deaf cultures. However, there appears to be little written about the experiences of hearing children born to Deaf parents in the South African context.This study sought to investigate the roles of children of Deaf adults (CODAs) as interpreters in Deaf (...) of interpreting services for Deaf people in South Africa in the form of professional interpreters rather than the reliance on hearing children as interpreters in order to mediate between Deaf and hearing cultures.

2018 African journal of disability

16. Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss Full Text available with Trip Pro

Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss To investigate the role of intratympanic (IT) therapy in the treatment of idiopathic sudden sensorineural hearing loss (ISSNHL).This study was a retrospective review. Patients were treated for ISSNHL from January 1, 2011 to April 12, 2015 with the following: pre/posttreatment audios, treatment initiated ≤90 days and idiopathic etiology. Fifty-three ISSNHL patients were analyzed in the following subgroups

2018 Laryngoscope investigative otolaryngology

17. Age‐related hearing loss: Unraveling the pieces Full Text available with Trip Pro

Age‐related hearing loss: Unraveling the pieces Age-related hearing loss (ARHL) is the most common cause of hearing loss in the world. The development of ARHL in each individual is multifactorial, involving both intrinsic and extrinsic factors. This review highlights several of the key findings in the ARHL literature and discusses future directions.NA.

2018 Laryngoscope investigative otolaryngology

18. ADHEAR System for Conductive Hearing Loss: Clinical Effectiveness

ADHEAR System for Conductive Hearing Loss: Clinical Effectiveness ADHEAR System for Conductive Hearing Loss: Clinical Effectiveness | CADTH.ca Find the information you need ADHEAR System for Conductive Hearing Loss: Clinical Effectiveness ADHEAR System for Conductive Hearing Loss: Clinical Effectiveness Last updated: November 8, 2018 Project Number: RA0983-000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What is the clinical (...) effectiveness of the ADHEAR system for patients with unilateral or bilateral conductive hearing loss? Key Message No relevant literature was identified regarding the clinical effectiveness of the ADHEAR system for patients with unilateral or bilateral conductive hearing loss. Files Rapid Response Reference List Published : November 8, 2018 Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review

19. Assessment of hearing loss

ear (sensory) or auditory nerve/auditory pathway (neural). Many sensorineural hearing losses are permanent because the human inner ear and hair cells have only limited ability to repair themselves, unlike avian hair cells, which can re-generate after trauma or injury. Reng D, Müller M, Smolders JWT. Functional recovery of hearing following AMPA-induced reversible disruption of hair cell afferent synapses in the avian inner ear. Audiol Neurootol. 2001 Mar-Apr;6(2):66-78. http://www.ncbi.nlm.nih.gov (...) Assessment of hearing loss Assessment of hearing loss - Differential diagnosis of symptoms | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Assessment of hearing loss Last reviewed: February 2019 Last updated: December 2018 Summary Hearing loss is one of the most common sensory impairments. It affects people of all ages and can be permanent if not treated correctly. Proper diagnosis rests on a thorough understanding of ear anatomy and physiology

2018 BMJ Best Practice

20. Addressing the rising prevalence of hearing loss

Addressing the rising prevalence of hearing loss Addressing the rising prevalence of hearing loss JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Addressing the rising prevalence of hearing loss View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2018)‎. Addressing the rising prevalence of hearing loss. World Health Organization. . License

2018 WHO